Primer: Silexion Therapeutics (SLXN US) - Aug 2026
Silexion Therapeutics is a clinical-stage biotechnology company at the forefront of developing RNA interference (RNAi) therapies for...
88 Views
𝛼SK or SearchENTITY
Silexion Therapeutics (SLXN US)
Silexion Therapeutics (SLXN US)
3
Analysis
Health Care • United States
Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company developing proprietary RNA interference (RNAi) therapies for KRAS-driven cancers. The company is offering shares and warrants in a best-efforts offering to advance its pre-clinical and clinical studies and for general corporate purposes.
morex